BarbaraADegarMD

Clinical Trials

• Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2008 Aug 04

  Completed

  Phase 3

• Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis Start of enrollment: 2013 Jul 01

  Completed

  Phase 2, Phase 3

• A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody Start of enrollment: 2014 Aug 04

  Completed

  Phase 2, Phase 3

• LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Start of enrollment: 2016 Nov 02

  Recruiting

  Phase 2, Phase 3

• Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders Start of enrollment: 2015 May 01

  Active, not recruiting

  Phase 2

• A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2017 Jun 15

  Active, not recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis Start of enrollment: 2021 Jul 13

  Recruiting

  Phase 1, Phase 2

  Roles: Contact, Principal Investigator

• Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders Start of enrollment: 2021 Apr 19

  Recruiting

  Phase 2

  Roles: Contact

• Join now to see all